Anti-Signal Recognition Particle Autoantibody in Patients with and Patients Without Idiopathic Inflammatory Myopathy

Arthritis and Rheumatism

Volumn 50, Issue 1, 2004, Pages 209-215

  Kao, Amy H ^a   Lacomis, David ^a   Lucas, Mary ^a   Fertig, Noreen ^a   Oddis, Chester V ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b S703 Biomedical Science Tower ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; SIGNAL RECOGNITION PARTICLE; SIGNAL RECOGNITION PARTICLE ANTIBODY; SYNTHETASE ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; DERMATOMYOSITIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEART DISEASE; HUMAN; HUMAN TISSUE; MALE; MUSCLE ATROPHY; MUSCLE BIOPSY; MUSCLE WEAKNESS; MYOSITIS; POLYMYOSITIS; PRIORITY JOURNAL; SEROLOGY; SURVIVAL; SYSTEMIC SCLEROSIS;

ADULT; AGED; ANTIBODY SPECIFICITY; AUTOANTIBODIES; DERMATOMYOSITIS; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MUSCLE, SKELETAL; POLYMYOSITIS; SCLERODERMA, SYSTEMIC; SIGNAL RECOGNITION PARTICLE;

EID: 0347719282     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.11484     Document Type: Article

References (17)

1. Miller FW. Myositis specific autoantibodies: touchstones for understanding the inflammatory myopathies. JAMA 1993;270:1846-9.
2. Targoff IN, Johnson AE, Miller FW. Antibody to signal recognition particle in polymyositis. Arthritis Rheum 1990;33:1361-70.
3. Love LA, Leff RL, Fraser DD, Targoff IN, Dalakas M, Plotz PH, et al. A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine (Baltimore) 1991;70:360-74.
4. Plotz P, Targoff I. Myositis-associated antigens: aminoacyl-tRNA synthetases Jo-1, PL-7, PL-12, EJ and OJ. In: Van Venrooij WJ, Maini R, editors. Manual of biologic markers of disease. Dordrecht: Kluwer Academic Publishers; 1994. p. B6.1/1-18.
5. Hirakata M, Suwa A, Sato S, Nojima T, Kaneko Y, Akizuki M, et al. Clinical features of Japanese patients with anti-SRP autoantibodies: the immunogenetic backgrounds [abstract]. Arthritis Rheum 2002;46 Suppl 9:S611.
6. Brouwer R, Hengstman GJ, Vree Egberts W, Ehrfeld H, Bozic B, Ghirardello A, et al. Autoantibody profiles in the sera of European patients with myositis. Ann Rheum Dis 2001;60:116-23.
7. Reeves WH, Nigam SK, Blobel G. Human autoantibodies reactive with the signal-recognition particle. Proc Natl Acad Sci U S A 1986;83:9507-11.
8. Okada N, Mimori T, Mukai R, Kashiwagi H, Hardin JA.Characterization of human autoantibodies that selectively precipitate the 7SL RNA component of the signal recognition particle. J Immunol 1987;138:3219-23.
9. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975;292:344-7.
10. Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med 1975;292:403-7.
11. Pincus T, Summey JA, Soraci SA Jr, Wallston KA, Hummon NP. Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire. Arthritis Rheum 1983;26:1346-53.
12. Okano Y, Steen VD, Medsger TA Jr. Autoantibody to U3 small nucleolar ribonucleoprotein (fibrillarin) in patients with systemic sclerosis. Arthritis Rheum 1992;35:95-100.
13. Bunn CC, Bernstein RM, Mathews MB. Autoantibodies against alanyl-tRNA synthetase and tRNAala coexist and are associated with myositis. J Exp Med 1986;163:1281-91.
14. Gelpí C, Kanterewicz E, Gratacos J, Targoff IN, Rodriguez-Sanchez JL. Coexistence of two antisynthetases in a patient with the antisynthetase syndrome. Arthritis Rheum 1996;39:692-7.
15. Mitri GM, Lucas M, Fertig N, Steen VD, Medsger TA Jr. A comparison between anti-Th/To- and anticentromere antibody-positive systemic sclerosis patients with limited cutaneous involvement. Arthritis Rheum 2003;48:203-9.
16. Marie I, Hatron PY, Levesque H, Hachulla E, Hellot MF, Michon-Pasturel U, et al. Influence of age on characteristics of polymyositis and dermatomyositis in adults. Medicine (Baltimore) 1999;78:139-47.
17. Miller T, Al-Lozi MT, Lopate G, Pestronk A. Myopathy with antibodies to the signal recognition particle: clinical and pathologic features. J Neurol Neurosurg Psychiatry 2002;73:420-8.